Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Patents google com us8829195 asciminib?Scemblix medication cost 2026?Voltaren for back pain?Is relistor expensive?Suzetrigine clinical trials?
See the DrugPatentWatch profile for vraylar
Vraylar (cariprazine) has a long effective half-life. After dosing, cariprazine’s pharmacokinetic half-life is reported as about 2 to 4 days for the parent drug, with very long terminal half-lives for its active metabolites—about 1 to 3 weeks—because they persist in the body.
Vraylar’s prolonged effects come from those long-lived active metabolites. Even if the parent drug levels fall relatively quickly, metabolites keep contributing to overall drug activity for weeks.
Because the clinically active metabolite half-lives are on the order of weeks, drug effects and the time to reach low levels can also take several weeks, not just days. The exact timeline varies by dose and individual metabolism.
Other Questions About Vraylar :